Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus

被引:44
作者
Jakhar, Deepak [1 ,2 ]
Kaur, Ishmeet [1 ,2 ]
机构
[1] North Delhi Municipal Corp Med Coll, Dept Dermatol, New Delhi, India
[2] Hindu Rao Hosp, New Delhi, India
关键词
D O I
10.1038/s41591-020-0853-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:632 / 632
页数:1
相关论文
共 6 条
[1]  
[Anonymous], 2020, WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020
[2]   Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities [J].
Biot, C ;
Daher, W ;
Chavain, N ;
Fandeur, T ;
Khalife, J ;
Dive, D ;
De Clercq, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (09) :2845-2849
[3]  
Cao R, 2020, CELL RES, V30, P269, DOI [DOI 10.1038/S41422-020-0282-0, 10.1038/s41422-020-0282-02020, DOI 10.1038/s41422-020-0282-0]
[4]  
multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]
[5]   Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology [J].
Schrezenmeier, Eva ;
Doerner, Thomas .
NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (03) :155-166
[6]   In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [J].
Yao, Xueting ;
Ye, Fei ;
Zhang, Miao ;
Cui, Cheng ;
Huang, Baoying ;
Niu, Peihua ;
Liu, Xu ;
Zhao, Li ;
Dong, Erdan ;
Song, Chunli ;
Zhan, Siyan ;
Lu, Roujian ;
Li, Haiyan ;
Tan, Wenjie ;
Liu, Dongyang .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :732-739